Form 4: ISRG SVP Brosius Reports Equity Vesting, Tax Withholding

Intuitive Surgical's SVP Mark Brosius reported the vesting of restricted and performance stock units, alongside associated tax withholdings.

Summary

• Mark Brosius, SVP & Chief Mfg and Supply Chain at Intuitive Surgical Inc (ISRG), reported transactions involving common stock.
• On February 28, 2026, 877 shares of common stock were acquired upon the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.0.
• Concurrently, 435 shares of common stock were disposed of at $503.51 to cover statutory tax withholding requirements related to the RSU vesting.
• Also on February 28, 2026, 8,378 shares of common stock were acquired upon the vesting of Performance Stock Units (PSUs) at an exercise price of $0.0, following the achievement of certain performance metrics as determined by the Compensation Committee.
• An additional 4,155 shares of common stock were disposed of at $503.51 to cover taxes applicable to the settlement of these PSUs.
• Following these transactions, Brosius directly beneficially owns 6,564 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine disclosure of executive equity compensation vesting and associated tax withholdings, which is neither inherently positive nor negative for the company's operational or financial performance.

Positives

• SVP Mark Brosius received 877 shares from RSU vesting and 8,378 shares from PSU vesting, indicating successful achievement of performance metrics for PSUs.
• The vesting of equity awards represents a compensation benefit for the executive, aligning their interests with shareholder value.

Negatives

• A significant portion of vested shares (435 shares for RSUs and 4,155 shares for PSUs) were withheld to cover statutory tax obligations, reducing the net shares received by the executive.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions like equity award vesting and tax-related sales are common across the medical device and technology sectors, reflecting standard executive compensation practices rather than strategic shifts.

Comparison to Industry Standards

• StockSavvy.ai observes that the structure of equity compensation, including RSUs and PSUs with multi-year vesting schedules and performance criteria, aligns with common practices among large-cap technology and medical device companies such as Medtronic, Johnson & Johnson, and Stryker, which also utilize similar long-term incentive plans to align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: Minimal direct impact, as these are routine compensation events. The executive's increased ownership (net of taxes) aligns interests with shareholders.
• Employees: Reflects standard executive compensation practices for senior leadership.

Key Dates

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, Stock Vesting, Restricted Stock Units, Performance Stock Units, Executive Compensation, Mark Brosius